mGluR5 acts as an important cofactor, its chronic activation can enhance NMDA receptors (NMDARs) activity and further amplify neuronal excitotoxicity [37]
Additionally, LDNs effect on opioid receptors can positively impact mood and alleviate fatigue, creating a holistic improvement in patients quality of life [28,29,30,31,53]
The level of significance at which the null hypothesis was rejected was P 0.05
I mean, we just can't accept, you know, across the healthcare system, providers and hospitals just sending us Bill charges and expecting us just to pay whatever they ask
Other genes that have been more studied in the adult population, TM6SF2 (E167K variant) and MBOAT7, need to be further explored in pediatric MASLD/MASH [12,13,15]